Methods for Estimating Microbial Density in Specimens by Measurement of Ribosomal RNA
AssigneesMicrobeDX Inc., The Regents of the University of California
InventorsBernard Churchill, Scott Adam Churchman, David Arnold Haake, Colin Wynn Halford, Roger Knauf, Gabriel Monti, Victoria Scott
Life of this patent
Estimating the term…
Abstract
A method of determining a bacterial density in a specimen may include the steps of: (a) conducting an RNA assay on the specimen to determine a microbial rRNA concentration, wherein the microbial rRNA concentration is defined as the number of rRNA molecules per volume of the specimen; and (b) converting the rRNA concentration to a bacterial density value.
Claims18
A method of determining a bacterial density value in a specimen, the method comprising:
- (a) obtaining a specimen to be analyzed;
- (b) conducting an RNA assay on the specimen including the steps of:
- i) lysing the specimen to release bacterial rRNA using at least mechanical lysis;
- ii) neutralizing the released rRNA;
- iii) hybridizing the released rRNA with capture and detector probes to form one or more capture probe-rRNA-detector probe complexes;
- and
- iv) detecting the capture probe-rRNA-detector probe complexes;
- to determine a bacterial rRNA concentration in the specimen, wherein the bacterial rRNA concentration is defined as a number of rRNA molecules per volume of the specimen;
- (c) converting the bacterial rRNA concentration to a bacterial density value;
- and
- (d) displaying the bacterial density value to a user via a user display apparatus.
A method of determining if a subject has an infection, comprising
- (a) conducting a rRNA assay on a clinical specimen from the subject including the steps of:
- i) lysing the specimen to release bacterial rRNA using at least mechanical lysis;
- ii) neutralizing the released rRNA;
- iii) hybridizing the released rRNA with capture and detector probes to form one or more capture probe-rRNA-detector probe complexes;
- and
- iv) detecting the capture probe-rRNA-detector probe complexes;
- to determine a bacterial rRNA concentration, wherein the bacterial rRNA concentration is defined as a number of rRNA molecules per volume of the specimen;
- (b) converting the bacterial rRNA concentration to the bacterial density value and displaying the bacterial density value to a user via a user display;
- and
- (c) determining if the subject has the infection by comparing the bacterial density value with a predetermined infection threshold value of the subject related to the clinical specimen.
A method of determining a dilution factor of a clinical specimen to use in a direct-from-specimen phenotypic antimicrobial susceptibility test, the method comprising:
- (a) conducting a rRNA assay on the clinical specimen to determine a bacterial rRNA concentration, wherein the bacterial rRNA concentration is defined as a number of rRNA molecules per volume of the specimen;
- and
- (b) converting the bacterial rRNA concentration to a bacterial density value;
- and
- (c) comparing the bacterial density value to a target inoculation concentration for use in a phenotypic antimicrobial susceptibility test, wherein
- if the bacterial density value is greater than the target inoculation concentration then further including the step of diluting the clinical specimen so that the bacterial density value is equal to or less than the target inoculation concentration before conducting the phenotypic antimicrobial susceptibility test, or
- if the bacterial density value is less than the target inoculation concentration then further including the step of conducting the phenotypic antimicrobial susceptibility test without diluting the clinical specimen.
Dependencies are inferred from the claim text.